129 related articles for article (PubMed ID: 10643343)
1. [Registration of complications after transfusion--"hemovigilance"].
Jørgensen JR; Taaning EB
Ugeskr Laeger; 1999 Nov; 161(48):6610-2. PubMed ID: 10643343
[No Abstract] [Full Text] [Related]
2. Health outcomes research using large donor-recipient databases: a new frontier for assessing transfusion safety and contributing to public health.
Busch M; Custer B
Vox Sang; 2006 Nov; 91(4):282-4. PubMed ID: 17105602
[No Abstract] [Full Text] [Related]
3. Registration of trials in children: update of current international initiatives.
Pandolfini C; Bonati M; Sammons HM
Arch Dis Child; 2009 Sep; 94(9):717-9. PubMed ID: 19457883
[No Abstract] [Full Text] [Related]
4. [Hemovigilance--a new name or an old, unfulfilled need].
Heier HE
Tidsskr Nor Laegeforen; 2000 Aug; 120(18):2185. PubMed ID: 11006745
[No Abstract] [Full Text] [Related]
5. [Is Danish donor blood contagious?].
Georgsen J
Ugeskr Laeger; 2001 May; 163(19):2613. PubMed ID: 11360352
[No Abstract] [Full Text] [Related]
6. [International databases: usefulness and limitations in hemovigilance].
Wiersum-Osselton JC
Transfus Clin Biol; 2010 Dec; 17(5-6):306-9. PubMed ID: 21055991
[TBL] [Abstract][Full Text] [Related]
7. Transfusion medicine teaching for harmonisation of blood transfusion practice in Europe.
Rossi U
Beitr Infusionsther Transfusionsmed; 1994; 32():524-30. PubMed ID: 9422128
[TBL] [Abstract][Full Text] [Related]
8. Blood transfusion in Europe--The White Book 2005: the patchwork of transfusion medicine in Europe.
Mayr WR
Transfus Clin Biol; 2005 Nov; 12(5):357-8. PubMed ID: 16326127
[TBL] [Abstract][Full Text] [Related]
9. Transfusion medicine and safety.
Dodd R; Kurt Roth W; Ashford P; Dax EM; Vyas G
Biologicals; 2009 Apr; 37(2):62-70. PubMed ID: 19230706
[TBL] [Abstract][Full Text] [Related]
10. [Infections as complications of blood transfusion]].
Kłos M
Przegl Epidemiol; 2001; 55 Suppl 3():4-9. PubMed ID: 11984956
[No Abstract] [Full Text] [Related]
11. Response to the international forum on haemovigilance.
Wiersum-Osselton JC; Schipperus MR
Vox Sang; 2006 Oct; 91(3):278-9. PubMed ID: 16958843
[No Abstract] [Full Text] [Related]
12. European strategies against the parasite transfusion risk.
Reesink HW
Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
[TBL] [Abstract][Full Text] [Related]
13. [How much is enough?].
Flesland Ø; Solheim BG
Tidsskr Nor Laegeforen; 2001 Aug; 121(20):2421. PubMed ID: 11603055
[No Abstract] [Full Text] [Related]
14. [Cochrane. The missing link?].
Ahnfeldt-Mollerup I
Ugeskr Laeger; 2003 Sep; 165(38):3639; author reply 3639. PubMed ID: 14556401
[No Abstract] [Full Text] [Related]
15. [Transfusion medicine--Scandinavian recommendations].
Gudmundsson S; Jørgensen J; Koistinen J; Kornstad L; Messeter L
Nord Med; 1997 Apr; 112(4):129-30. PubMed ID: 9198811
[No Abstract] [Full Text] [Related]
16. [Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries].
Andersen O
Lakartidningen; 2002 Mar; 99(12):1310-4. PubMed ID: 11998162
[No Abstract] [Full Text] [Related]
17. Residual risks of blood transfusion in Rhode Island.
Sweeney JD; Kurtis J; Starakiewicz J
Med Health R I; 2005 Jul; 88(7):224-5, 228-31. PubMed ID: 16184827
[No Abstract] [Full Text] [Related]
18. Evolution of microbial safety.
Barbara JA
Hematol J; 2004; 5 Suppl 3():S69-73. PubMed ID: 15190282
[No Abstract] [Full Text] [Related]
19. [The European Network of Transfusion Medicine Societies (EuroNet-TMS)].
Velati C;
Transfus Clin Biol; 2004; 11(5-6):255-6. PubMed ID: 15946880
[No Abstract] [Full Text] [Related]
20. The risk of transfusion-transmitted prion infections.
Rodriguez F; Macalintal Rodriguez N
MLO Med Lab Obs; 2000 Apr; 32(4):24-8, 30-1. PubMed ID: 10947455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
